No quarterly data; standalone H1 FY27 revenue up 25.07%, profit after tax up 2.28%
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
No consolidated latest-quarter figures were provided; standalone results for the half year ended September 30, 2026 show revenue of ₹76.49 crore versus ₹61.16 crore a year earlier, up 25.07%. EBITDA was ₹10.14 crore versus ₹8.88 crore, up 14.13%, while profit after tax was ₹6.27 crore versus ₹6.27 crore, up 2.28%. Margins eased. Talod capacity rose from 720 MT to 4,500 MT after about ₹20 crore spending.
Higher revenue and added capacity support growth, but H1 margin compression and slower profit growth may limit near-term shareholder gains.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹76.49 Cr | ₹61.16 Cr | +25.1% |
| Operating profit | ₹7.95 Cr | ₹7.52 Cr | +5.7% |
| Profit after tax | — | — | — |
| EBITDA margin | — | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.